Research analysts who have asked questions during KB Financial Group earnings calls.
Do Ha Kim
Hanwha Investment & Securities
3 questions for KB
Baek Do san
Korea Investment & Securities
2 questions for KB
Doosan Baek
Korea Investment & Securities Co., Ltd.
2 questions for KB
Hye-jin Park
Daishin Securities Co., Ltd.
2 questions for KB
Jaeong Won
HSBC
2 questions for KB
Jihyun Cho
JPMorgan Chase & Co.
2 questions for KB
Jung Joon seok
Mirae Asset Securities
2 questions for KB
Jun-Sup Jung
NH Investment & Securities Co., Ltd.
2 questions for KB
Kim Do
Hanoi Investment & Securities
2 questions for KB
Kim Joo
Samsung Securities
2 questions for KB
Miseon Lee
Citigroup Inc.
2 questions for KB
Jae Woo Kim
Not Disclosed in Transcript
1 question for KB
Jaewoong Won
HSBC Securities
1 question for KB
Shim Jongmin
CLSA Securities
1 question for KB
Yong Jin Seol
SK Securities Co., Ltd.
1 question for KB
Recent press releases and 8-K filings for KB.
- Orum Therapeutics secured 145 billion KRW (approximately US$100 million) in convertible preferred stock investments.
- The funding round was led by returning investor KB Investment and included new investors such as Weiss Asset Management and Korea Investment Partners.
- This investment will support advancing therapeutic programs, including ORM-1153, toward clinical development, expanding discovery across novel payload classes, and broadening global capabilities.
- KB Financial Group Inc. reported a consolidated profit of W 5,101,930 million for the nine-month period ended September 30, 2025, an increase from W 4,368,778 million in the prior year period.
- The company's consolidated total assets grew to W 796,063,202 million as of September 30, 2025, up from W 757,845,532 million at year-end 2024.
- Separate basic earnings per share for the nine-month period ended September 30, 2025, was W 5,774, compared to W 5,392 for the same period in 2024.
- The company's shareholder return policy targets a Return on Equity (ROE) of 10% or above and a CET1 ratio of 13% or above, utilizing quarterly cash dividends and share buybacks/cancellations.
- In 2025, KB Financial Group resolved to acquire and cancel treasury shares, including 3,047,395 shares acquired between April 28 and June 30, 2025, slated for cancellation on January 15, 2026.
- AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a" (Excellent) for KB Insurance Co., Ltd. (KBI), with a stable outlook.
- The ratings reflect KBI's strong balance sheet strength, adequate operating performance, neutral business profile, appropriate enterprise risk management, and the support it receives from its parent, KB Financial Group Inc..
- KBI's risk-adjusted capitalisation is assessed at the strongest level, and it holds a stable market share of approximately 13% in the South Korean non-life insurance market based on gross insurance service revenue in 2024.
- KBI's operating performance is deemed adequate, with its return-on-equity and combined ratios largely in line with domestic industry peers, despite facing headwinds from an industry-wide increase in medical claims in 2025 and negative underwriting pressure in its auto line.
- KB Financial Group Inc. declared a quarterly cash dividend of KRW 930 per common share.
- The total dividend amount is KRW 335,731,836,750, assuming 361,001,975 outstanding shares.
- The record date for the dividend is November 14, 2025, with payment expected within one month following the October 30, 2025 resolution date.
- The total dividend amount is subject to adjustment based on the actual number of outstanding shares as of the record date, due to the acquisition of treasury shares.
- KB Financial Group (Consolidated) reported profit attributable to shareholders of the parent company of 1,686,040 million Won in Q3 2025, marking a 4.09% increase year-over-year, despite a 3.33% decrease in operating revenue to 14,972,327 million Won compared to Q3 2024.
- Cumulatively, KB Financial Group's profit attributable to shareholders of the parent company for the first nine months of 2025 reached 5,121,733 million Won, an increase of 16.56% compared to the same period in 2024.
- Kookmin Bank, a key subsidiary, saw its profit attributable to shareholders of the parent company grow by 5.84% year-over-year to 1,176,943 million Won in Q3 2025, although its operating revenue declined by 18.12% year-over-year to 6,444,666 million Won.
- KB Securities reported a 17.31% year-over-year increase in operating revenue to 2,746,467 million Won in Q3 2025, but its profit attributable to shareholders of the parent company decreased by 7.47% year-over-year to 159,172 million Won.
- KB Financial Group Inc. provided an update on its ongoing share buyback program, which commenced on July 24, 2025.
- As of October 24, 2025, the company acquired 2,870,000 common shares for 324,887 million KRW through a trust agreement.
- The total contracted amount for the share acquisition program is 660,000 million KRW, and the acquisition is still ongoing.
Quarterly earnings call transcripts for KB Financial Group.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more